Related Experiment Videos
[An experimental study on tissue renin-angiotensin-aldosterone system]
1Department of Cardiology, Nanfang Hospital, First Military Medical University, Guangzhou.
Zhonghua Nei Ke Za Zhi
|August 7, 1999
Summary
Aldosterone can be synthesized in the kidney, not just the adrenal gland. Angiotensin converting enzyme inhibitors (ACEI) like perindopril also inhibit vascular aldosterone synthesis, impacting blood vessel remodeling.
Area of Science:
- Endocrinology
- Nephrology
- Cardiovascular Science
Context:
- The adrenal gland is traditionally considered the primary site of aldosterone biosynthesis.
- The role of local tissue synthesis of aldosterone and its regulation remains an active area of research.
Purpose:
- To investigate the potential for aldosterone biosynthesis in kidney tissue and vascular tissue.
- To explore the effects of angiotensin converting enzyme inhibitors (ACEI) on vascular aldosterone synthesis and remodeling.
Summary:
- Aldosterone biosynthesis was confirmed in kidney tissue using in vitro perfusion, HPLC, RIA, and TR-PCR, demonstrating extra-adrenal production.
- In nephrectomized rats, vascular tissue maintained renin mRNA expression, indicating local renin-angiotensin-aldosterone system initiation independent of circulating renin.
- Perindopril, an ACEI, was shown to inhibit both angiotensin II production and aldosterone synthesis within vascular tissue, suggesting a mechanism for its effects on vascular remodeling.
Impact:
- Establishes the kidney as a site for aldosterone production, expanding our understanding of endocrine regulation.
- Highlights the vasculature's intrinsic capacity to generate aldosterone, implicating local mechanisms in cardiovascular homeostasis.
- Suggests that ACEI-mediated vascular remodeling may be partly due to the inhibition of local aldosterone synthesis.